Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Thomas U. Marron; Matthew D. Galsky; Bachir Taouli; Maria Isabel Fiel; Stephen Ward; Edward Kim; David Yankelevitz; Deborah Doroshow; Emma Guttman-Yassky; Benjamin Ungar; Saurabh Mehandru; Benjamin J. Golas; Daniel Labow; John Sfakianos; Sujit S. Nair; Dimple Chakravarty; Michael Buckstein; Xiaoyu Song; Effi Kenigsberg; Sacha Gnjatic; Brian D. Brown; Joseph Sparano; Ashutosh Tewari; Myron Schwartz; Nina Bhardwaj; Miriam Merad

doi:10.1038/s41591-022-01948-3

Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Thomas U. Marron, Matthew D. Galsky, Bachir Taouli, Maria Isabel Fiel, Stephen Ward, Edward Kim, David Yankelevitz, Deborah Doroshow, Emma Guttman-Yassky, Benjamin Ungar, Saurabh Mehandru, Benjamin J. Golas, Daniel Labow, John Sfakianos, Sujit S. Nair, Dimple Chakravarty, Michael Buckstein, Xiaoyu Song, Effi Kenigsberg, Sacha GnjaticBrian D. Brown, Joseph Sparano, Ashutosh Tewari, Myron Schwartz, Nina Bhardwaj, Miriam Merad

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	1723
Number of pages	1
Journal	Nature Medicine
Volume	28
Issue number	8
DOIs	https://doi.org/10.1038/s41591-022-01948-3
State	Published - Aug 2022

Access to Document

10.1038/s41591-022-01948-3

Cite this

Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., Mehandru, S., Golas, B. J., Labow, D., Sfakianos, J., Nair, S. S., Chakravarty, D., Buckstein, M., Song, X., Kenigsberg, E., ... Merad, M. (2022). Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x). Nature Medicine, 28(8), 1723. https://doi.org/10.1038/s41591-022-01948-3

@article{181f50998ebe4b8e9f93ab54c3cbb47a,

title = "Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)",

abstract = "In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.",

author = "Marron, {Thomas U.} and Galsky, {Matthew D.} and Bachir Taouli and Fiel, {Maria Isabel} and Stephen Ward and Edward Kim and David Yankelevitz and Deborah Doroshow and Emma Guttman-Yassky and Benjamin Ungar and Saurabh Mehandru and Golas, {Benjamin J.} and Daniel Labow and John Sfakianos and Nair, {Sujit S.} and Dimple Chakravarty and Michael Buckstein and Xiaoyu Song and Effi Kenigsberg and Sacha Gnjatic and Brown, {Brian D.} and Joseph Sparano and Ashutosh Tewari and Myron Schwartz and Nina Bhardwaj and Miriam Merad",

note = "Publisher Copyright: {\textcopyright} 2022, Springer Nature America, Inc.",

year = "2022",

month = aug,

doi = "10.1038/s41591-022-01948-3",

language = "English",

volume = "28",

pages = "1723",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "8",

}

Marron, TU , Galsky, MD , Taouli, B , Fiel, MI , Ward, S , Kim, E, Yankelevitz, D, Doroshow, D , Guttman-Yassky, E , Ungar, B , Mehandru, S, Golas, BJ, Labow, D , Sfakianos, J, Nair, SS, Chakravarty, D, Buckstein, M , Song, X, Kenigsberg, E, Gnjatic, S , Brown, BD, Sparano, J, Tewari, A , Schwartz, M , Bhardwaj, N & Merad, M 2022, 'Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)', Nature Medicine, vol. 28, no. 8, pp. 1723. https://doi.org/10.1038/s41591-022-01948-3

TY - JOUR

T1 - Author Correction

T2 - Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

AU - Marron, Thomas U.

AU - Galsky, Matthew D.

AU - Taouli, Bachir

AU - Fiel, Maria Isabel

AU - Ward, Stephen

AU - Kim, Edward

AU - Yankelevitz, David

AU - Doroshow, Deborah

AU - Guttman-Yassky, Emma

AU - Ungar, Benjamin

AU - Mehandru, Saurabh

AU - Golas, Benjamin J.

AU - Labow, Daniel

AU - Sfakianos, John

AU - Nair, Sujit S.

AU - Chakravarty, Dimple

AU - Buckstein, Michael

AU - Song, Xiaoyu

AU - Kenigsberg, Effi

AU - Gnjatic, Sacha

AU - Brown, Brian D.

AU - Sparano, Joseph

AU - Tewari, Ashutosh

AU - Schwartz, Myron

AU - Bhardwaj, Nina

AU - Merad, Miriam

PY - 2022/8

Y1 - 2022/8

N2 - In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

AB - In the version of this article initially published, the last name of author Emma Guttman-Yassky was incomplete and has now been amended in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85134466255&partnerID=8YFLogxK

U2 - 10.1038/s41591-022-01948-3

DO - 10.1038/s41591-022-01948-3

M3 - Comment/debate

AN - SCOPUS:85134466255

SN - 1078-8956

VL - 28

SP - 1723

JO - Nature Medicine

JF - Nature Medicine

IS - 8

ER -

Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)

Abstract

Access to Document

Fingerprint

Cite this